If the Nyrada IPO was over-subscribed, as seems likely, this...

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    If the Nyrada IPO was over-subscribed, as seems likely, this will be another indication that the Noxopharm market cap of $34 million is an aberration.

    Noxopharm will own about 40% of Nyrada, fully diluted. NOX ownership of Nyrada will be worth:

    $13 m at the IPO price of 20 cents
    $32 m at 50 cents
    $64 m at one dollar

    Strong demand for the IPO will be reflected in the Nyrada share price, once it lists, which will be good for NOX shareholders as well. It looks like the buy-side agrees.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.8¢
Change
0.000(0.00%)
Mkt cap ! $28.63M
Open High Low Value Volume
9.7¢ 9.8¢ 9.5¢ $15.43K 159.9K

Buyers (Bids)

No. Vol. Price($)
1 47773 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 47899 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.